News
Smithies named to first class of the Fellows of the AACR Academy
Oliver Smithies did not set out to become one of the world’s foremost pioneers in cancer research. He merely had a question that needed answering.
Lymphedema therapy provides relief for cancer patients
“It’s a lifesaver.” That’s how Frances Patterson, a breast cancer patient, describes the therapy she receives for lymphedema through the UNC Comprehensive Cancer Support Program.
Storming the gates – UNC research probes how pancreatic cancers metastasize
Researchers at the University of North Carolina at Chapel Hill have discovered that a protein found in the cells surrounding pancreatic cancers play a role in the spread of the disease to other parts of the body.
Ribisl quoted by Huffington Post on New York cigarette law
Ribisl predicts that new regulations preventing the open display of cigarettes in stores could lead to a reduction in smoking over time.
Dibbert named Hometown Hero by WCHL
Debbie Dibbert, Director of External Affairs at UNC Lineberger, was named as a Hometown Hero by WCHL 97.9 and Chapelboro.com.
Ting awarded 2013 University Award for the Advancement of Women
Jenny Ting, PhD, W.R. Kenan, Jr. Distinguished Professor of Microbiology and Immunology, has been awarded a 2013 University Award for the Advancement of Women.
Pignone tapped to lead new UNC Institute for Health Care Quality Improvement
Michael Pignone, MD, MPH, Professor of Medicine and Division Chief of General Medicine and Epidemiology, has been named director of the UNC Institute for Health Care Quality Improvement, which aims to establish UNC as the leading academic medical center in the area of clinical quality improvement. The new institute is a product of the UNC School of Medicine’s Strategic Plan.
Smith authors commentary on first population-based study of HPV vaccine effectiveness
For the first time, a population-based study of a human papillomavirus (HPV) vaccine has proven that the vaccine is effective in reducing the incidence of genital warts.
Cohen and Damania elected as 2013 Fellows of the American Academy of Microbiology
Two members of the UNC Lineberger Comprehensive Cancer Center have been elected as 2013 Fellows of the American Academy of Microbiology (AAM), the honorific leadership group within the American Society for Microbiology (ASM).
General surgeons perform majority of cancer procedures in the United States
A study by Karyn Stitzenberg, MD, MPH, assistant professor of surgery and member of the UNC Lineberger Comprehensive Cancer Center, shows that surgical oncologists comprise only a small portion of the number of surgeons who perform cancer surgery.
UNC School of Medicine named Best Medical School for Primary Care
The School ranked 1st in Primary Care and 22nd in Research overall in the 2014 U.S. News & World Report Best Medical School Rankings. Family Medicine, Rural Medicine and AIDS were also listed as top ten specialties.
News & Observer profiles nurse practitioners at N.C. Cancer Hospital
To meet a growing need for nurses with advanced training, the University of North Carolina and five other UNC-system schools will offer a doctorate in nursing this fall. The News and Observer article discusses the need and role that will be filled by the new Doctors of Nursing Practice.
Muss on the long-term sides effects of chemotherapy for breast cancer
The journal Oncology's online Cancer Network profiled an address given by Hyman Muss, MD, professor of medicine, at the 30th Annual Miami Breast Cancer Conference in March.
Helper molecule with ‘Mary Poppins-like’ qualities smooths out RNA folding
Researchers at the University of North Carolina at Chapel Hill have discovered how helper molecules, or chaperones, aid in the RNA folding process, resolving a fundamental conundrum about how these important biological molecules work.
New chemical probe provides tool to investigate role of malignant brain tumor domains in chromatin structure and regulation
In an article published as the cover story of the March 2013 issue of Nature Chemical Biology, Lindsey James, PhD, research assistant professor in the lab of Stephen Frye, Fred Eshelman Distinguished Professor in the UNC Eshelman School of Pharmacy and member of the UNC Lineberger Comprehensive Cancer Center, announced the discovery of a chemical probe that can be used to investigate the L3MBTL3 methyl-lysine reader domain. The probe, named UNC1215, will provide researchers with a powerful tool to investigate the function of malignant brain tumor (MBT) domain proteins in biology and disease.
Genomic screening to detect preventable rare diseases in healthy people
Experts from the UNC School of Medicine and the UNC Gillings School of Global Public Health propose that screening healthy adults for preventable diseases such as colorectal cancer, breast cancer, and several catastrophic blood vessel disorders, among others, could potentially prevent these diseases.
Global Women's Health featured on WTVD
A UNC Lineberger-affiliated program that provides HIV and cervical cancer testing in Malawi and Zambia was featured on the Raleigh-Durham ABC affiliate.
Endeavors - Firefly Mice
Could glowing rodents come to the aid of cancer researchers … and patients?
Hayes lab documents head and neck cancer molecular tumor subtypes
Head and neck squamous cell carcinoma (HNSCC) is the seventh most common form of cancer in the United States, but other than an association with the human papillomavirus, no validated molecular profile of the disease has been established. By analyzing data from DNA microarrays, a UNC-led team has completed a study that confirms the presence of four molecular classes of the disease and extends previous results by suggesting that there may be an underlying connection between the molecular classes and observed genomic events, some of which affect known cancer genes. The clinical relevance of the classes and certain genomic events was demonstrated, thus paving the way for further studies and possible targeted therapies.
Evans discusses clinical genomics on Radio In Vivo
James Evans, Bryson Distinguished Professor of Genetics and Medicine, was interviewed about his work as principal investigator on the NCGENES Study with WCOM 103.5's Radio In Vivo.
